CJC-1295 5mg Without DAC + IPA 5mg (10mg) x 10 vials (100mg)

CJC-1295 Without DAC + Ipamorelin – 10mg (Blend)

CJC-1295 Without DAC combine with Ipamorelin is a popular peptide  widely used in laboratory research exploring growth hormone signalling pathways. This combination pairs a short-acting Growth Hormone Releasing Hormone (GHRH) analogue with a Growth Hormone Releasing Peptide (GHRP), allowing researchers to study their synergistic interaction within controlled experimental environments.

CJC-1295 Without DAC functions by stimulating the natural release of growth hormone through the pituitary gland. When combine with Ipamorelin, a selective ghrelin receptor agonist, the two peptides work together to support research into pulsatile growth hormone release and endocrine response.

This dual-peptide formulation is commonly select for experimental protocols investigating hormone signalling, metabolic regulation, recovery pathways, and tissue repair mechanisms.

Key Features

• 10mg total peptide content per vial
• Combination of CJC-1295 Without DAC and Ipamorelin
• Lyophilised powder for research applications
• High-purity material suitable for laboratory study
• Securely sealed vial to maintain compound stability

Storage

Store in a cool, dry place away from direct light. For stability, refrigeration is recommend once reconstitute.

Important Notice

This product is  strictly for laboratory research purposes only. It is not for human consumption, medical use, or veterinary application. All research must be conduct by qualified professionals in appropriate laboratory settings.